Methods are disclosed for treating congestive heart failure with partial inhibitors of fatty acid oxidation. The compounds increase cardiac performance without affecting heart rate, blood pressure, or oxygen consumption.
This is a continuation of application U.S. patent application Ser. No. 09/784,559 filed Feb. 15, 2001, now U.S. Pat. No. 6,528,511, which claims priority to U.S. Provisional Patent Application No. 60/183,560 filed on Feb. 18, 2000 and U.S. Provisional Patent Application No. 60/219,908 filed on Jul. 21, 2000.
